Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 165.50
+1.30 (0.79%)
Aug 15, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 148.55 billion as of August 15, 2025. Its market cap has increased by 334.34% in one year.
Market Cap
148.55B
Enterprise Value
144.87B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
165.50
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 148.55B, an increase of 701.05%. That is a compound annual growth rate of 47.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 148.55B | 172.65% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 266.94B |
| Hansoh Pharmaceutical Group Company | 223.44B |
| JD Health International | 175.53B |
| Innovent Biologics | 164.42B |
| Sino Biopharmaceutical | 136.28B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.10B |